Yi Li

Title: Yi Li - Innovator in Vaccine Development

Introduction

Yi Li is a notable inventor based in East Lansing, MI (US). He has made significant contributions to the field of vaccine development, particularly in the area of avian health. His work focuses on innovative solutions to combat diseases affecting poultry.

Latest Patents

Yi Li holds a patent for a recombinant fowlpox vaccine designed to protect against Marek's disease. This recombinant fowlpox virus is engineered to include genes for various Marek's Disease Virus antigens, such as glycoprotein B homologue, glycoprotein C homologue, glycoprotein D homologue, glycoprotein H homologue, and tegument proteins. These components are controlled by a poxvirus promoter within a non-essential region of the fowlpox virus DNA, enhancing its efficacy as a vaccine.

Career Highlights

Throughout his career, Yi Li has worked with prominent organizations, including the United States of America as Represented by the Secretary of and Nippon Zeon Company, Ltd. His expertise in vaccine technology has positioned him as a key figure in the development of innovative solutions for poultry health.

Collaborations

Yi Li has collaborated with esteemed colleagues, including Lucy F Lee and Noboru Yanagida. These partnerships have contributed to the advancement of his research and the successful development of his patented vaccine.

Conclusion

Yi Li's contributions to vaccine development, particularly through his patented recombinant fowlpox vaccine, highlight his commitment to improving avian health. His work continues to influence the field and offers promising solutions for combating Marek's disease in poultry.